OTCBB Biotechnology StockAstralis, Ltd.Astralis, Ltd. currently has no significant operations and intends to engage in the research and development of treatments for immune system disorders and skin diseases. moreCtd Holdings, IncCTD Holdings, Inc. ("Us" or "the Company") was organized as a Florida corporation on August 9, 1990, with operations beginning in July 1992. We sell cyclodextrins ("Cyclodextrins" or "CDs") and related products to the food, pharmaceutical and other industries. We also provide consulting services in the area of commercialization of CD applications. morePolymedix, IncWe are a biotechnology company focused on treating infectious diseases and cardiovascular disorders with synthetic small molecule compounds that mimic the activity of large natural protein molecules, compounds referred to as biomimetics. All of our product candidates are in preclinical development. Using our proprietary computational drug design technology, we ... moreIntegrated Pharm, IncIntegrated Pharmaceuticals, Inc. is a biotechnology company engaged in the development and production of various chemicals and substances for the pharmaceutical, nutraceutical, and functional food industries. The company also takes part in the development of manufacturing processes using a technology platform that combines metabolic engineering, cellular genetics, advanced bioprocess ... moreNeostem, Inc.Phase III Medical, Inc., a Delaware corporation ("Phase III" or the "Company") is currently engaged in the business of operating a commercial autologous (donor and recipient are the same) adult stem cell bank and is pioneering the pre-disease collection, processing and storage of adult stem cells that donors can access for their own present and future medical treatment. The ... moreStellar PhamaceuticlStellar is a Canadian pharmaceutical company involved in the development and marketing of high quality, cost-effective, polysaccharide-based therapeutic products used in the treatment of osteoarthritis and certain types of cystitis. Stellar also intends to develop additional healthcare products aimed at niche pharmaceutical markets. Stellar’s product development strategy ... moreFermavir PharmaceutlWe are a development stage biotechnology company that has licensed patents for a series of compounds for the treatment of viral diseases including compounds for the treatment of VZV, the causative agent for shingles and chickenpox and CMV, a member of the herpes virus group which includes the viruses that cause chicken pox, mononucleosis, herpes labialis (cold sores) and genitalis (genital ... moreVioQuest Pharmaceuticals, Inc.VioQuest Pharmaceuticals, Inc. engages in the development of therapies for the treatment of oncology, and autoimmune disorders. moreLpath, Inc.Lpath, Inc. engages in the development of bioactive signaling lipids that are used to treat human diseases such as cancer, heart failure and age related macular degeneration.more Medistem Laboratories, Inc.Medistem Laboratories, Inc. engages in the development of stem cell based therapies for the treatment of various neurological, cardiovascular and auto immune diseases. moreUromed CorpUromed Corporation, a Delaware corporation, is sometimes referred to herein as "we", "us", "our", "Uromed", "Company" and the "Registrant". The Registrant was a biotechnology company formed in 1990 for the purpose of focusing on the development, manufacture and marketing of products for the management of urological and gynecological ... moreLipidviro Tech, IncFor a discussion of the business development of Lipidviro Tech, Inc., ("our Company" or "we," "our," "us" or words of similar import) for the years ended December 31, 2004, and 2003, see our 10-KSB Annual Reports for the years then ended, filed April 14, 2005, and April 14, 2004, respectively, with the Securities and Exchange Commission, and which are incorporated herein by this reference. ... moreAccess Pharmaceuticals, Inc.Access Pharmaceuticals, Inc. engages in the development of products for the treatment of cancer and other diseases. more Cellcyte Genetics CorporationCellcyte Genetics Corporation is a development stage company engaged in the research of stem cell therapeutic products for the treatment of oncology, diabetes, heart, liver, lung, and kidney diseases. moreStatsure DiagnosticAt the beginning of business on January 24, 2006, the Company effected a name change from Saliva Diagnostic Systems, Inc. to StatSure Diagnostic Systems, Inc., and the shares of the Company have been trading under that name, with the new symbol SSUR, since March 22, 2006. Coinciding with our corporate name change, the Company has changed the brand of ... more |
Featured Videos
Newest articles
